Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2014 | 06-2013 | 06-2012 | 06-2011 | 06-2010 | |
| Sales | 46,555 | 67,501 | 69,606 | 95,201 | 63,940 |
| Cost of Goods | 30,674 | 41,497 | 45,274 | 52,698 | 30,595 |
| Gross Profit | 15,881 | 26,004 | 24,331 | 42,503 | 33,345 |
| Operating Expenses | 13,871 | 17,186 | 16,063 | 25,127 | 19,194 |
| Operating Income | 2,685 | 9,314 | 8,543 | 18,074 | 14,746 |
| Interest Expense | 392 | 438 | 331 | 120 | 79 |
| Other Income | -2,905 | 163 | 398 | 1,760 | -143 |
| Pre-tax Income | -613 | 9,039 | 8,610 | 19,715 | 14,524 |
| Income Tax | 195 | 2,424 | 2,368 | 4,092 | 2,626 |
| Net Income Continuous | -808 | 6,615 | 6,242 | 15,623 | 11,898 |
| Minority Interests | -163 | -57 | -117 | -40 | 12 |
| Net Income | $-645 | $6,672 | $6,359 | $15,663 | $11,886 |
| EPS Basic Total Ops | -0.03 | 0.23 | 0.22 | 0.55 | 0.47 |
| EPS Basic Continuous Ops | -0.03 | 0.23 | 0.21 | 0.55 | 0.49 |
| EPS Diluted Total Ops | -0.03 | 0.23 | 0.22 | 0.53 | 0.40 |
| EPS Diluted Continuous Ops | -0.03 | 0.23 | 0.21 | 0.53 | 0.40 |
| EPS Diluted Before Non-Recurring Items | -0.03 | 0.23 | 0.22 | N/A | N/A |
| EBITDA(a) | $5,272 | $11,750 | $9,758 | $19,262 | $15,700 |